Bank of Montreal’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-306
| Closed | -$133K | – | 4516 |
|
|
2022
Q1 | $133K | Sell |
306
-14
| -4% | -$5.75K | ﹤0.01% | 3587 |
|
|
2021
Q4 | $146K | Sell |
320
-347
| -52% | -$174K | ﹤0.01% | 3040 |
|
|
2021
Q3 | $370K | Buy |
667
+81
| +14% | +$40.6K | ﹤0.01% | 3038 |
|
|
2021
Q2 | $309K | Buy |
586
+364
| +164% | +$231K | ﹤0.01% | 3045 |
|
|
2021
Q1 | $219K | Sell |
222
-89
| -29% | -$60.9K | ﹤0.01% | 3071 |
|
|
2020
Q4 | $184K | Buy |
311
+163
| +110% | +$85.4K | ﹤0.01% | 3266 |
|
|
2020
Q3 | $73K | Sell |
148
-4
| -3% | -$2.32K | ﹤0.01% | 3256 |
|
|
2020
Q2 | $97K | Buy |
152
+63
| +71% | +$34.8K | ﹤0.01% | 3109 |
|
|
2020
Q1 | $41K | Sell |
89
-887
| -91% | -$482K | ﹤0.01% | 2974 |
|
|
2019
Q4 | $566K | Buy |
976
+64
| +7% | +$44.9K | ﹤0.01% | 2601 |
|
|
2019
Q3 | $600K | Buy |
912
+13
| +1% | +$10.8K | ﹤0.01% | 2309 |
|
|
2019
Q2 | $695K | Buy |
899
+79
| +10% | +$55.5K | ﹤0.01% | 2246 |
|
|
2019
Q1 | $579K | Sell |
820
-12
| -1% | -$7.18K | ﹤0.01% | 2235 |
|
|
2018
Q4 | $389K | Buy |
832
+6
| +0.7% | +$3.87K | ﹤0.01% | 2274 |
|
|
2018
Q3 | $711K | Buy |
826
+1
| +0.1% | +$722 | ﹤0.01% | 2160 |
|
|
2018
Q2 | $569K | Buy |
825
+5
| +0.6% | +$2.54K | ﹤0.01% | 2275 |
|
|
2018
Q1 | $365K | Sell |
820
-944
| -54% | -$458K | ﹤0.01% | 2351 |
|
|
2017
Q4 | $777K | Hold |
1,764
| – | – | ﹤0.01% | 2068 |
|
|
2017
Q3 | $868K | Buy |
1,764
+694
| +65% | +$348K | ﹤0.01% | 2042 |
|
|
2017
Q2 | $593K | Hold |
1,070
| – | – | ﹤0.01% | 2192 |
|
|
2017
Q1 | $708K | Buy |
1,070
+250
| +30% | +$134K | ﹤0.01% | 1977 |
|
|
2016
Q4 | $266K | Buy |
820
+815
| +16,300% | +$262K | ﹤0.01% | 2376 |
|
|
2016
Q3 | $2K | Hold |
5
| – | – | ﹤0.01% | 3873 |
|
|
2016
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 4003 |
|
|
2016
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 4103 |
|
|
2015
Q4 | $3K | Hold |
5
| – | – | ﹤0.01% | 3923 |
|
|
2015
Q3 | $3K | Hold |
5
| – | – | ﹤0.01% | 3749 |
|
|
2015
Q2 | $2K | Hold |
5
| – | – | ﹤0.01% | 3779 |
|
|
2015
Q1 | $2K | Buy |
+5
| New | +$1.89K | ﹤0.01% | 3808 |
|
|
2014
Q3 | – | Sell |
-4
| Closed | -$2K | – | 4458 |
|
|
2014
Q2 | $2K | Buy |
+4
| New | +$2.15K | ﹤0.01% | 4521 |
|
Other funds holding TVRD
BCLSI
FCM
DGI
KCM
C
Bank of Montreal's TVRD Position: Q2 2022 in Review
Bank of Montreal sold out of Tvardi Therapeutics (TVRD) in Q2 2022, closing a stake of 306 shares — an estimated $133K sold.
Bank of Montreal first reported a position in TVRD in Q2 2014 and held it in 30 quarters. The position peaked at $868K in Q3 2017. 179 funds tracked by Wall St. Rank hold TVRD as of Q2 2022.
- Bank of Montreal reported no remaining Tvardi Therapeutics position as of Q2 2022 after selling out during the quarter.
- Bank of Montreal sold 306 Tvardi Therapeutics shares in Q2 2022, an estimated $133K.
- Bank of Montreal first reported a position in Tvardi Therapeutics in Q2 2014 and held it in 30 quarters.
- Bank of Montreal's Tvardi Therapeutics position peaked at $868K in Q3 2017.
- 179 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2022.
Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.